PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'RAND Corporation, Arlington, VA, United States of America. Electronic address: luscherp@rand.org.\', \'RAND Corporation, Boston, MA, United States of America.\', \'Greater Los Angeles VA Medical Center, Los Angeles, CA, United States of America.\', \'Department of Health Care Policy, Harvard Medical School, Boston, MA, United States of America; Beth Israel Deaconess Medical Center, Boston, MA, United States of America.\', \'Harvard T. H. Chan School of Public Health Boston, MA, United States of America.\', \'Department of Health Care Policy, Harvard Medical School, Boston, MA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0740-5472(20)30380-910.1016/j.jsat.2020.108124
?:hasPublicationType
?:journal
  • Journal of substance abuse treatment
is ?:pmid of
?:pmid
?:pmid
  • 32893047
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.311
?:rankingScore_hIndex
  • 91
?:title
  • Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32893047>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32893047>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all